Tumor necrosis factor superfamily molecules in acute coronary syndromes
Authors:
- 2 November 2010
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 43 (2) , 90-103
Abstract
Accumulating evidence suggests that inflammatory pathways play an essential role in all stages of atherogenesis. Inflammatory processes are not only involved in plaque progression, but seem also to play a critical role in plaque rupture. Members of the tumor necrosis factor (TNF) superfamiliy are potent regulators of inflammation and cell survival and consist of 20 ligands that signal through 29 different receptors. Several lines of evidence suggest that TNF-related molecules are involved in the development of acute coronary syndromes (ACS). Most, convincing evidence exists for CD40 ligand-CD40 interaction, but several other members of the TNF superfamily seem also to be involved in this immune-mediated promotion of plaque instability, including LIGHT, receptor activator of nuclear factor κB ligand, and TNF-α. These plaque destabilization pathways involve the bidirectional interaction between platelets and endothelial cells/monocytes, activation of vascular smooth muscle cells, and co-stimulatory effects on T cells, promoting inflammation, thrombus formation, matrix degradation, and apoptosis. TNF-related pathways could contribute to the non-resolving inflammation that characterizes atherosclerosis, representing pathogenic loops that are operating during plaque rupture and the development of ACS. These TNF-related molecules could also represent attractive new targets for therapy in this disorder.Keywords
This publication has 122 references indexed in Scilit:
- Impaired Infarct Healing in Atherosclerotic Mice With Ly-6ChiMonocytosisJACC, 2010
- Nonresolving InflammationCell, 2010
- Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileJournal of Experimental Medicine, 2010
- Dendritic cells in atherosclerotic diseaseClinical Immunology, 2010
- The role of CD40 and CD154/CD40L in dendritic cellsSeminars in Immunology, 2009
- Osteoprotegerin, vascular calcification and atherosclerosisAtherosclerosis, 2009
- Innate and adaptive immunity in atherosclerosisSeminars in Immunopathology, 2009
- Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18European Heart Journal, 2008
- Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2007
- NF-κB at the crossroads of life and deathNature Immunology, 2002